I don’t know how does you feel about the fact, but I find myself very badly advised when Palantir takes over the health management and datatracking.
The „solutions company“ and the Final Solution
The Holocaust had six stages: identify the Jews, isolate them, exclude them and seize their assets, put them in ghettos, deport them and, finally, exterminate them. According to Black’s research, IBM Hollerith machines had a part in each one.
IBM’s machines tabulated and tracked census information in order to identify Jewish populations across Europe. Hollerith machines tracked the coming and going of passenger and freight trains, and managed the populations of the concentration camps. The numerical tattoo inked on the arms of Auschwitz prisoners? It was originally an IBM identification number used to track that prisoner in the punch card system.
A common strategy for global corporations to exonerate themselves from Nazi ties is to claim they’d lost control or influence over their German offices and subsidiaries. Ford and GM claimed as much in the 1990s.
But the machines IBM leased to the Germans weren’t simply sold to the Nazis; everything was leased and regularly maintained by IBM technicians, some of who serviced the tabulation machines biweekly on-site at the concentration camps. IBM chairman and CEO Thomas Watson, who visited the Third Reich multiple times and dined with Hitler, approved the construction of aEurope-wide school for Hollerith technicians who could implement and maintain the machines, which ran on proprietary punch cards made on special paper.
This Is the Hidden Nazi History of IBM — And the Man Who Tried to Expose It
Artificial intelligence is ripe for abuse, tech researcher warns: ‚a fascist’s dream‘
https://www.cbsnews.com/news/ibm-and-nazi-germany/
https://www.itbusiness.ca/news/ibms-darkest-chapter-controversy-over-second-world-war/16394
CDC Partners with Palantir to Bolster the Fight Against COVID-19
22. Februar 2022 by Palantir Media
- Palantir’s software will continue to power the digital operating system for the U.S. public health response to the pandemic
- The agreement marks an expansion of Palantir’s role supporting the U.S. fight against the COVID-19 pandemic, from vaccine distribution to new areas such as improving supply chain resiliency and the distribution of life-saving therapeutics
- Palantir has been a longtime partner of the CDC on crucial public health issues, including countering Ebola, surveillance of food borne illness, and the management of anthrax and bacterial special pathogens
February 22, 2022 06:59 AM Eastern Standard Time
DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (Palantir, NYSE: PLTR) a leading builder of operating systems across the U.S. Government, announced it had been selected by the Centers for Disease Control and Prevention (CDC) to expand its role as a trusted technology partner in the federal COVID-19 response by supporting key distribution and supply-chain efforts.
The Department of Health and Human Services selected Palantir in mid-2020 to power Tiberius, the platform originally configured to support vaccine distribution. Building on its successful implementation of Tiberius, the government will be able to leverage its existing technology investment in Palantir’s modular and flexible software platform to support additional workflows such as distribution of life-saving therapeutics.???
This contract was awarded to Palantir by the CDC for $5.3 million for the duration of six months. Palantir’s software empowers organizations to effectively integrate their data, decisions, and operations. It is designed to scale with increasing complexity, making it particularly suited to bring data-driven solutions to some of the world’s most difficult problems, including management of COVID-19 vaccines, pediatric vaccines, therapeutics, and more.
„A successful federal response to COVID requires real time situational awareness to manage rapidly changing epidemiology,“ said Dr. Bill Kassler, Palantir’s chief medical officer – USG. „Palantir’s technology provides public health officials, from the federal to the local levels, with the tools they need to make informed, up-to-date decisions about sending medications and other resources where they are needed most.“
“We are honored to support the CDC’s efforts in the fight against the COVID-19 pandemic and build upon our work at other U.S. government agencies,” said Akash Jain, president of Palantir USG. “Helping the government solve the most pressing public policy challenges, whether they be in defense, intelligence, or in today’s case, public health, is core to our company’s mission. We are humbled to continue to earn the trust of the CDC for this critical work.”
About Palantir Technologies Inc.
Palantir Technologies is a technology company that builds enterprise data platforms for use by organizations with complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and nonprofit sectors transform the way they use their data. Additional information is available at https://www.palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
Contacts
Lisa Gordon media@palantir.com
Palantir hires former IBM Watson Health exec as its first US government chief medical officer
PUBLISHED MON, MAY 3 2021
KEY POINTS
- Palantir hired its first U.S. government chief medical officer from IBM as the data analytics company doubles down on its life sciences business.
- While the company made its name in software used by government defense agencies, its health-care sector has become its fastest-growing U.S. government business, doubling over the past year.
- In his new role, Dr. Bill Kassler wants to help put Palantir’s technology in the hands of researchers who can use it to make smart decisions in the next pandemic.
A pedestrian passes a banner displaying Palantir Technologies signage during the company’s initial public offering, New York Stock Exchange, Sept. 30, 2020.
Michael Nagle | Bloomberg | Getty Images
Palantir has hired its first U.S. government chief medical officer, a former executive from IBM’s Watson Health business, as the data analytics company doubles down on its life sciences business.
While the company made its name in software used by government defense agencies, sales to health-related agencies in the federal government have doubled over the last year.The company announced Monday its has hired Dr. Bill Kassler to lead public health and life sciences teams across Palantir’s domestic and global businesses.
Kassler, formerly deputy chief health officer at IBM Watson Health, said in an exclusive interview with CNBC that he would bring his expertise in clinical care and public health to the role, helping to connect the software to researchers who could benefit from it.“Palantir is just an exciting group of young, talented engineers and data scientists and real, real intelligent, smart people,” he said. “But in order to deploy technology, you have to understand the theory and the logic and the practice of health care and public health. And I think we see a lot of technology companies that want to get into health but don’t know that, make mistakes because they’re not intimately familiar. And what I can bring to Palantir is my expertise as a clinician, as a public health doc, as somebody who has been working in this field for years to help with the science and the strategy and the relationships.”Investing in tech for the next pandemicIn his new role, Kassler said, he wants to help put Palantir’s technology in the hands of researchers who can use it to make smart decisions in the next pandemic.
He highlighted three areas he believes can be improved with the help of tech solutions like Palantir’s: patching supply chain issues, dealing with localized surges of cases, and tackling racial and ethnic disparities. Palantir’s Foundry platform has played a significant role in the U.S. government’s response to the Covid-19 pandemic as well as private companies’ handling of essential supply chains. Palantir’s technology allows researchers to combine and overlay data sets in ways that can make supply chain weaknesses or outbreak hot spots more obvious, allowing them to act quickly on their findings.On the government side, the National Institutes of Health has recently begun using Palantir’s platform to combine data sets from 50 different academic groups that it funds in ways that would have been cumbersome without the software.Palantir’s technology helps the groups share data in ways that protects patient identities but allows them to gain more insights by analyzing a much larger data set than they would have access to in their individual group settings. Julie Bush, who leads Palantir’s federal health-care work, said the data is now being used to better understand how Covid has impacted people with different backgrounds and conditions.Bush said such broad data-sharing was less common prior to the pandemic, but she hopes it continues after.“People love to hoard their data,” she said. “And the pandemic really forced people to come together and be willing to share information and sort of set the bureaucracy aside. And, of course subject to data use agreements and other things, what we really saw was incredible collaborations happening across the government.”Kassler said he wants to see the technology used for more everyday use cases, too. One example he gave is how the Centers for Disease Control and Prevention has already used the technology to help narrow the possible sources of an outbreak linked to produce. Rather than recalling produce from a large region, Palantir can help the agency trace the supply chain and pinpoint a smaller target.“We don’t know what the next pandemic will be,” Kassler said. “So we have to be prepared. And in order to do that, we have to have invested in the systems that are able to have that situational awareness and to be able to enable organizations to respond quickly.”WATCH: Palantir CFO describes the seven-year journey to bring the company public
Federal Health Impact
Palantir technology powers connectivity across federal, state, and local health departments to combat COVID-19.
“Palantir’s technology provides public health officials, from the federal to the local levels, with the tools they need to make informed, up-to-date decisions about sending medications and other resources where they are needed most.”
Dr. Bill Kassler, Palantir’s Chief Medical Officer – USG
The COVID-19 Pandemic
In response to the COVID-19 pandemic, U.S. government teams needed to quickly coordinate data-driven operations across public, private, and academic organizations.
Decision-makers across the healthcare spectrum, from local healthcare providers to federal officials, needed a single, reliable platform that provided up-to-date information on testing and positivity rates, clinical cases, hospitalizations, mortality, impacts of school closures and stay-at-home orders. Moreover, these decision-makers were required to coordinate and allocate life-saving medical resources like testing kits, therapeutics, personal protective equipment (PPE), and vaccines.
Questions like “Do we have enough PPE?” sounded simple, but answering them quickly was nearly impossible. It required near real-time collaboration between federal and local governments and public and private sector organizations and insight from data, models, and logic from diverse source systems—backed by granular access controls.
Connecting Public Health Infrastructure
In April 2020, HHS leadership and the CDC began using Palantir software to establish a connected public health data foundation. This empowered cross-government teams from over 30 federal agencies and over 50 state and local health departments to securely collaborate with public and private sector organizations in order to fight the COVID-19 pandemic.
As of August 2022, government response teams are continuing to generate timely insights through the integration of critical information. Information from hospitals; school districts; commercial and public health laboratories; federal and state surveillance, preparedness, and response (SPR) systems; pharmaceutical manufacturers; public and private pharmacies; healthcare providers; medical countermeasure and PPE suppliers; socioeconomic indices; and disease forecasting is integrated and analyzed to power coordinated operations that protect public health.
Coordinating Data-Driven Government Operations
This centralized data foundation has enabled shared situational awareness for the CDC and pandemic response teams, comprised of over 3,900 public, private, industry and academic users. For the first time, cross-sector teams could work together to efficiently answer critical questions, such as “Are resources distributed equitably?” and take coordinated actions, including allocating federal supplies to jurisdictions for acceptance and distribution. This same information backs communication to the public by federal and state teams through applications, tools, and public websites like the COVID Data Tracker and jurisdictional dashboards.
The COVID-19 pandemic required “all hands on deck” across the entire U.S. healthcare system and highlighted the need for improved data sharing, common federal and local government operations, and collaboration across the public and private sectors. Palantir Foundry proudly supports the shared IT infrastructure that empowers public health action.
Impact
Foundry empowers:
↳ Data-driven government policy, resourcing, and operational decision-making—within actionable timelines.
↳ Near real-time coordination of critical information across federal and local government teams.
↳ Sustained public health supply chain visibility through public-private collaboration.
Palantir and U.S. Government to Continue Work on COVID-19 Vaccine Distribution
26. Juli 2021by Palantir Media
Palantir’s software powers Tiberius, HHS’s vaccine rollout platform
DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE:PLTR), the leading builder of operating systems for the modern enterprise, announced today that the U.S. Department of Health and Human Services has renewed its commitment to working with Palantir to support COVID-19 vaccine distribution for another year.
Palantir will work with HHS’s Office of the Chief Information Officer (OCIO) and provide its software platform to help manage the U.S. COVID-19 vaccine distribution strategy, enable international distribution, and improve the equity and efficacy of vaccine programs. The contract duration is for one year.
Palantir’s software enables organizations to improve their data-driven decision-making process by integrating disparate data sources into a single common operating picture. Palantir was commissioned in mid-2020 by the Department of Health and Human Services to build Tiberius, a software platform it uses to track vaccine production, distribution, and administration across the United States.
For this renewed contract, Palantir will continue to support Tiberius, which gives local, state and federal health officials a comprehensive platform to track vaccine distribution and administration. It will also help U.S. officials facilitate the distribution of American-donated vaccines in an effort to halt the progression of the pandemic worldwide.
“We are proud to have supported HHS in administering one of the most successful and rapid vaccine rollouts in the world,” said Akash Jain, President of Palantir USG. “As new variants emerge and pose a renewed risk to public health in the United States and around the world, we are humbled to have earned the confidence of HHS once again to help support its lifesaving work.”
Palantir has played a key role in mitigating the global COVID-19 pandemic in the U.S. and abroad, supporting more than 100 organizations in their response to the pandemic, including with the U.K.’s National Health Service and across the U.S. government and military.
About Palantir Technologies
Palantir Technologies is a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments. From building safer cars and planes, to discovering new drugs and combating terrorism, Palantir helps customers across the public, private, and nonprofit sectors transform the way they use their data. Additional information is available at https://www.palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, Palantir’s expectations regarding the amount and the terms of the contract and the expected benefits of our software platforms. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include our ability to meet the unique needs of our customer; the failure of our platforms to satisfy our customer or perform as desired; the frequency or severity of any software and implementation errors; our platforms’ reliability; and our customer’s ability to modify or terminate the contract. Additional information regarding these and other risks and uncertainties is included in the filings we make with the Securities and Exchange Commission from time to time. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.
Contacts
Lisa Gordon media@palantir.com
IMPACT STUDIES
- Airbus
- Axel Springer
- Cleveland Clinic
- Concordance
- Doosan Infracore
- Ferrari
- Fujitsu
- Grupo Globo
- HHS & CDC
- Jacobs
- Kinder Morgan
- NHS
- Pacific Gas & Electric
- Ringier
- Sonnedix
- SOMPO
- Swiss Re
- Tampa General Hospital
- World Food Programme
https://www.forbes.com/sites/edwardsegal/2021/05/06/how-we-can-prepare-today-for-the-next-pandemic/
https://finance.yahoo.com/news/palantir-backs-multiple-spacs-endeavors-181143200.html
JULIMINATION 
Hinterlasse einen Kommentar